Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Kidney Int ; 102(1): 173-182, 2022 07.
Artigo em Inglês | MEDLINE | ID: mdl-35483528

RESUMO

While females can suffer serious complications of Fabry disease, most studies are limited to males to avoid confounding by mosaicism. Here, we developed a novel unbiased method for quantifying globotriaosylceramide (GL3) inclusion volume in affected podocytes (F+) in females with Fabry disease independent of mosaicism leading to important new observations. All podocytes in male patients with Fabry are F+. The probability of observing random profiles from F+ podocytes without GL3 inclusions (estimation error) was modeled from electron microscopic studies of 99 glomeruli from 40 treatment-naïve males and this model was applied to 28 treatment-naïve females. Also, podocyte structural parameters were compared in 16 age-matched treatment-naïve males and females with classic Fabry disease and 11 normal individuals. A 4th degree polynomial equation best described the relationship between podocyte GL3 volume density and the estimation error (R2 =0.94) and was confirmed by k-fold cross-validation. In females, this model showed that age related directly to F+ podocyte GL3 volume (correlation coefficient (r = 0.54) and podocyte volume (r = 0.48) and inversely to podocyte number density (r = -0.56), (all significant). F+ podocyte GL3 volume was significantly inversely related to podocyte number density (r = -0.79) and directly to proteinuria. There was no difference in F+ podocyte GL3 volume or volume fraction between age-matched males and females. Thus, in females with Fabry disease GL3 accumulation in F+ podocytes progresses with age in association with podocyte loss and proteinuria, and F+ podocyte GL3 accumulation in females with Fabry is similar to males, consistent with insignificant cross-correction between affected and non-affected podocytes. Hence, these findings have important pathophysiological and clinical implications.


Assuntos
Doença de Fabry , Podócitos , Doença de Fabry/complicações , Feminino , Humanos , Masculino , Proteinúria/etiologia , Triexosilceramidas
2.
EMBO J ; 34(21): 2633-51, 2015 Nov 03.
Artigo em Inglês | MEDLINE | ID: mdl-26330466

RESUMO

Interest in RNA dysfunction in amyotrophic lateral sclerosis (ALS) recently aroused upon discovering causative mutations in RNA-binding protein genes. Here, we show that extensive down-regulation of miRNA levels is a common molecular denominator for multiple forms of human ALS. We further demonstrate that pathogenic ALS-causing mutations are sufficient to inhibit miRNA biogenesis at the Dicing step. Abnormalities of the stress response are involved in the pathogenesis of neurodegeneration, including ALS. Accordingly, we describe a novel mechanism for modulating microRNA biogenesis under stress, involving stress granule formation and re-organization of DICER and AGO2 protein interactions with their partners. In line with this observation, enhancing DICER activity by a small molecule, enoxacin, is beneficial for neuromuscular function in two independent ALS mouse models. Characterizing miRNA biogenesis downstream of the stress response ties seemingly disparate pathways in neurodegeneration and further suggests that DICER and miRNAs affect neuronal integrity and are possible therapeutic targets.


Assuntos
Esclerose Lateral Amiotrófica/genética , MicroRNAs/biossíntese , Esclerose Lateral Amiotrófica/tratamento farmacológico , Esclerose Lateral Amiotrófica/patologia , Animais , Sequência de Bases , Grânulos Citoplasmáticos/metabolismo , RNA Helicases DEAD-box/metabolismo , Regulação para Baixo , Avaliação Pré-Clínica de Medicamentos , Enoxacino/farmacologia , Feminino , Células HEK293 , Humanos , Masculino , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , MicroRNAs/genética , Neurônios Motores/metabolismo , Interferência de RNA , Processamento Pós-Transcricional do RNA , Ribonuclease III/metabolismo , Estresse Fisiológico , Superóxido Dismutase/genética , Superóxido Dismutase-1
3.
J Immunol ; 192(1): 358-66, 2014 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-24319262

RESUMO

Neuroinflammation occurs in acute and chronic CNS injury, including stroke, traumatic brain injury, and neurodegenerative diseases. Microglia are specialized resident myeloid cells that mediate CNS innate immune responses. Disease-relevant stimuli, such as reactive oxygen species (ROS), can influence microglia activation. Previously, we observed that p53, a ROS-responsive transcription factor, modulates microglia behaviors in vitro and in vivo, promoting proinflammatory functions and suppressing downregulation of the inflammatory response and tissue repair. In this article we describe a novel mechanism by which p53 modulates the functional differentiation of microglia both in vitro and in vivo. Adult microglia from p53-deficient mice have increased expression of the anti-inflammatory transcription factor c-Maf. To determine how p53 negatively regulates c-Maf, we examined the impact of p53 on known c-Maf regulators. MiR-155 is a microRNA that targets c-Maf. We observed that cytokine-induced expression of miR-155 was suppressed in p53-deficient microglia. Furthermore, Twist2, a transcriptional activator of c-Maf, is increased in p53-deficient microglia. We identified recognition sites in the 3' untranslated region of Twist2 mRNA that are predicted to interact with two p53-dependent microRNAs: miR-34a and miR-145. In this article, we demonstrate that miR-34a and -145 are regulated by p53 and negatively regulate Twist2 and c-Maf expression in microglia and the RAW macrophage cell line. Taken together, these findings support the hypothesis that p53 activation induced by local ROS or accumulated DNA damage influences microglia functions and that one specific molecular target of p53 in microglia is c-Maf.


Assuntos
MicroRNAs/genética , Microglia/metabolismo , Proteínas Proto-Oncogênicas c-maf/genética , Proteína Supressora de Tumor p53/metabolismo , Animais , Isquemia Encefálica/genética , Isquemia Encefálica/metabolismo , Linhagem Celular , Modelos Animais de Doenças , Regulação da Expressão Gênica , Humanos , Masculino , Camundongos , Camundongos Knockout , MicroRNAs/metabolismo , Modelos Biológicos , Fenótipo , Proteínas Proto-Oncogênicas c-maf/metabolismo , Proteínas Repressoras/genética , Proteínas Repressoras/metabolismo , Proteína Supressora de Tumor p53/genética , Proteína 1 Relacionada a Twist/genética , Proteína 1 Relacionada a Twist/metabolismo
4.
Inflammopharmacology ; 21(3): 253-9, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22492174

RESUMO

This study evaluates the migratory potential of monocytes isolated from two groups of human subjects: naïve and non-naïve to Cannabis. Phytocannabinoids (pCB), the bioactive agents produced by the plant Cannabis, regulate the phenotype and function of immune cells by interacting with CB1 and CB2 receptors. It has been shown that agents influencing the phenotype of circulating monocytes influence the phenotype of macrophages and the outcome of immune responses. To date, nothing is known about the acute and long-term effects of pCB on human circulating monocytes. Healthy subjects were recruited for a single blood draw. Monocytes were isolated, fluorescently labeled and their migration quantified using a validated assay that employs near infrared fluorescence and modified Boyden chambers. CB1 and CB2 receptor mRNA expression was quantified by qPCR. Monocytes from all subjects (n = 10) responded to chemokine (c-c motif) ligand 2 (CCL2) and human serum stimuli. Acute application of pCB significantly inhibited both the basal and CCL2-stimulated migration of monocytes, but only in subjects non-naïve to Cannabis. qPCR analysis indicates that monocytes from subjects non-naïve to Cannabis express significantly more CB1 mRNA. The phenotype of monocytes isolated from subjects non-naïve to Cannabis is significantly different from monocytes isolated from subjects naïve to Cannabis. Only monocytes from subjects non-naïve to Cannabis respond to acute exposure to pCB by reducing their overall migratory capacity. Our study suggests that chronic exposure to Cannabis affects the phenotype of circulating monocytes and accordingly could influence outcome of inflammatory responses occurring in injured tissues.


Assuntos
Canabinoides/farmacologia , Cannabis/química , Fumar Maconha/metabolismo , Monócitos/efeitos dos fármacos , Adulto , Canabinoides/administração & dosagem , Movimento Celular/efeitos dos fármacos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Monócitos/metabolismo , Projetos Piloto , Reação em Cadeia da Polimerase , RNA Mensageiro/metabolismo , Receptor CB1 de Canabinoide/metabolismo , Receptor CB2 de Canabinoide/metabolismo , Adulto Jovem
5.
Genet Mol Res ; 3(3): 432-40, 2004 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-15614733

RESUMO

Human consumption of soy-derived products has been limited by the presence of non-digestible oligosaccharides (NDO), such as the alpha-galactooligosaccharides raffinose and stachyose. Most mammals, including man, lack pancreatic alpha-galactosidase (alpha-Gal), which is necessary for the hydrolysis of these sugars. However, such NDO can be fermented by gas-producing microorganisms present in the cecum and large intestine, which in turn can induce flatulence and other gastrointestinal disorders in sensitive individuals. The use of microorganisms expressing alpha-Gal is a promising solution to the elimination of NDO before they reach the large intestine. In the present study, lactic acid bacteria engineered to degrade NDO have been constructed and are being used as a tool to evaluate this solution. The alpha-Gal structural genes from Lactobacillus plantarum ATCC8014 (previously characterized in our laboratory) and from guar have been cloned and expressed in Lactococcus lactis. The gene products were directed to different bacterial compartments to optimize their possible applications. The alpha-Gal-producing strains are being evaluated for their efficiency in degrading raffinose and stachyose: i) in soymilk fermentation when used as starters and ii) in situ in the upper gastrointestinal tract when administered to animals orally, as probiotic preparations. The expected outcomes and possible complications of this project are discussed.


Assuntos
Digestão , Lactobacillus plantarum/metabolismo , Lactococcus lactis/metabolismo , Oligossacarídeos/metabolismo , Rafinose/metabolismo , Leite de Soja/química , alfa-Galactosidase/genética , Animais , Produtos Fermentados do Leite , Fermentação , Alimentos Geneticamente Modificados , Lactobacillus plantarum/crescimento & desenvolvimento , Lactococcus lactis/crescimento & desenvolvimento , Probióticos , Roedores , alfa-Galactosidase/metabolismo
6.
Neuroreport ; 20(12): 1098-103, 2009 Aug 05.
Artigo em Inglês | MEDLINE | ID: mdl-19590393

RESUMO

Neuroinflammation is a prominent feature of many neurodegenerative diseases, however, little is known about neuroinflammation in Huntington's disease. We used quantitative real time-PCR to compare the expression level of neuroinflammation-associated mediators in the striatum, cortex, and cerebellum from post-mortem Huntington's disease patient samples with controls. We found increased expression of several key inflammatory mediators, including CCL2 and IL-10, specifically in the striatum of Huntington's disease patients, the main area affected by this pathology. Remarkably, we also found upregulation of IL-6, IL-8, and MMP9, in the cortex and notably the cerebellum, a brain area commonly thought to be spared by Huntington's disease. Our data suggest that neuroinflammation is a prominent feature associated with Huntington's disease and may constitute a novel target for therapeutic intervention.


Assuntos
Cerebelo/imunologia , Córtex Cerebral/imunologia , Corpo Estriado/imunologia , Doença de Huntington/imunologia , Adulto , Idoso , Cerebelo/metabolismo , Córtex Cerebral/metabolismo , Quimiocina CCL2/genética , Quimiocina CCL2/metabolismo , Corpo Estriado/metabolismo , Feminino , Expressão Gênica , Humanos , Doença de Huntington/genética , Doença de Huntington/metabolismo , Interleucina-10/genética , Interleucina-10/metabolismo , Interleucina-1beta/genética , Interleucina-1beta/metabolismo , Interleucina-6/genética , Interleucina-6/metabolismo , Interleucina-8/genética , Interleucina-8/metabolismo , Masculino , Metaloproteinase 9 da Matriz/genética , Metaloproteinase 9 da Matriz/metabolismo , Pessoa de Meia-Idade , RNA Mensageiro/metabolismo , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/metabolismo
7.
J Proteome Res ; 8(5): 2563-74, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19309132

RESUMO

All living organisms respond to changes in their internal and external environment for their survival and existence. Signaling is primarily achieved through reversible phosphorylation of proteins in both prokaryotes and eukaryotes. A change in the phosphorylation state of a protein alters its function to enable the control of cellular responses. A number of serine/threonine kinases regulate the cellular responses of eukaryotes. Although common in eukaryotes, serine/threonine kinases have only recently been identified in prokaryotes. We have described that the human pathogen Group B Streptococcus (GBS, Streptococcus agalactiae) encodes a single membrane-associated, serine/threonine kinase (Stk1) that is important for virulence of this bacterium. In this study, we used a combination of phosphopeptide enrichment and mass spectrometry to enrich and identify serine (S) and threonine (T) phosphopeptides of GBS. A comparison of S/T phosphopeptides identified from the Stk1 expressing strains to the isogenic stk1 mutant indicates that 10 proteins are potential substrates of the GBS Stk1 enzyme. Some of these proteins are phosphorylated by Stk1 in vitro and a site-directed substitution of the phosphorylated threonine to an alanine abolished phosphorylation of an Stk1 substrate. Collectively, these studies provide a novel approach to identify serine/threonine kinase substrates for insight into their signaling in human pathogens like GBS.


Assuntos
Proteínas de Bactérias/metabolismo , Fosfopeptídeos/análise , Proteínas Serina-Treonina Quinases/metabolismo , Streptococcus agalactiae/enzimologia , Alanina/genética , Alanina/metabolismo , Proteínas de Bactérias/genética , Sítios de Ligação/genética , Cromatografia Líquida/métodos , Humanos , Mutagênese Sítio-Dirigida , Mutação , Fosfopeptídeos/isolamento & purificação , Fosfopeptídeos/metabolismo , Fosforilação , Proteínas Serina-Treonina Quinases/genética , Proteômica/métodos , Reprodutibilidade dos Testes , Streptococcus agalactiae/genética , Especificidade por Substrato , Espectrometria de Massas em Tandem/métodos , Treonina/genética , Treonina/metabolismo
8.
J Exp Med ; 205(8): 1869-77, 2008 Aug 04.
Artigo em Inglês | MEDLINE | ID: mdl-18625748

RESUMO

Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by both neurological and systemic abnormalities. We examined the peripheral immune system and found widespread evidence of innate immune activation detectable in plasma throughout the course of HD. Interleukin 6 levels were increased in HD gene carriers with a mean of 16 years before the predicted onset of clinical symptoms. To our knowledge, this is the earliest plasma abnormality identified in HD. Monocytes from HD subjects expressed mutant huntingtin and were pathologically hyperactive in response to stimulation, suggesting that the mutant protein triggers a cell-autonomous immune activation. A similar pattern was seen in macrophages and microglia from HD mouse models, and the cerebrospinal fluid and striatum of HD patients exhibited abnormal immune activation, suggesting that immune dysfunction plays a role in brain pathology. Collectively, our data suggest parallel central nervous system and peripheral pathogenic pathways of immune activation in HD.


Assuntos
Doença de Huntington/imunologia , Animais , Estudos de Casos e Controles , Sistema Nervoso Central/imunologia , Sistema Nervoso Central/patologia , Citocinas/sangue , Citocinas/líquido cefalorraquidiano , Expressão Gênica , Humanos , Proteína Huntingtina , Doença de Huntington/genética , Doença de Huntington/patologia , Macrófagos/imunologia , Macrófagos/metabolismo , Camundongos , Camundongos Transgênicos , Microglia/imunologia , Microglia/metabolismo , Modelos Imunológicos , Monócitos/imunologia , Monócitos/metabolismo , Mutação , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/imunologia , Proteínas do Tecido Nervoso/metabolismo , Proteínas Nucleares/genética , Proteínas Nucleares/imunologia , Proteínas Nucleares/metabolismo , Expansão das Repetições de Trinucleotídeos
9.
Mol Microbiol ; 62(4): 941-57, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17005013

RESUMO

Signal transducing mechanisms are essential for regulation of gene expression in both prokaryotic and eukaryotic organisms. Regulation of gene expression in eukaryotes is accomplished by serine/threonine and tyrosine kinases and cognate phosphatases. In contrast, gene expression in prokaryotes is controlled by two-component systems that comprise a sensor histidine kinase and a cognate DNA binding response regulator. Pathogenic bacteria utilize two-component systems to regulate expression of their virulence factors and for adaptive responses to the external environment. We have previously shown that the human pathogen Streptococcus agalactiae (Group B Streptococci, GBS) encodes a single eukaryotic-type serine/threonine kinase Stk1, which is important for virulence of the organism. In this study, we aimed to understand how Stk1 contributes to virulence of GBS. Our results indicate that Stk1 expression is important for resistance of GBS to human blood, neutrophils and oxidative stress. Consistent with these observations, Stk1 positively regulates transcription of a cytotoxin, beta-haemolysin/cytolysin (beta-H/C) that is critical for survival of GBS in the bloodstream and for resistance to oxidative stress. Interestingly, positive regulation of beta-H/C by Stk1 requires the two-component regulator CovR. Further, we show that Stk1 can negatively regulate transcription of CAMP factor in a CovR-dependent manner. As Stk1 phosphorylates CovR in vitro, these data suggest that serine/threonine phosphorylation impacts CovR-mediated regulation of GBS gene expression. In summary, our studies provide novel information that a eukaryotic-type serine/threonine kinase regulates two-component-mediated expression of GBS cytotoxins.


Assuntos
Citotoxinas/genética , Regulação Bacteriana da Expressão Gênica , Proteínas Hemolisinas/genética , Proteínas Serina-Treonina Quinases/fisiologia , Transdução de Sinais , Streptococcus agalactiae/genética , Streptococcus agalactiae/metabolismo , Proteínas de Bactérias/metabolismo , Atividade Bactericida do Sangue , Proteínas Hemolisinas/metabolismo , Histidina Quinase , Humanos , Peróxido de Hidrogênio , Fagocitose , Pigmentos Biológicos/biossíntese , Proteínas Quinases/metabolismo , Proteínas Serina-Treonina Quinases/genética , Streptococcus agalactiae/imunologia , Fatores de Transcrição/metabolismo , Virulência/genética
10.
Mol Microbiol ; 56(5): 1329-46, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15882424

RESUMO

Group B streptococci (GBS) are the principal causal agents of human neonatal pneumonia, sepsis and meningitis. We had previously described the existence of a eukaryotic-type serine/threonine kinase (Stk1) and phosphatase (Stp1) in GBS that regulate growth and virulence of the pathogen. Our previous results also demonstrated that these enzymes reversibly phosphorylated an inorganic pyrophosphatase. To understand the role of these eukaryotic-type enzymes on growth of GBS, we assessed the stk1-mutants for auxotrophic requirements. In this report, we describe that in the absence of the kinase (Stk1), GBS are attenuated for de novo purine biosynthesis and are consequently growth arrested. During growth in media lacking purines, the intracellular G nucleotide pools (GTP, GDP and GMP) are significantly reduced in the Stk1-deficient strains, while levels of A nucleotides (ATP, ADP and AMP) are marginally increased when compared with the isogenic wild-type strain. We provide evidence that the reduced pools of G nucleotides result from altered activity of the IMP utilizing enzymes, adenylosuccinate synthetase (PurA) and IMP dehydrogenase (GuaB) in these strains. We also demonstrate that Stk1 and Stp1 reversibly phosphorylate and consequently regulate PurA activity in GBS. Collectively, these data indicate the novel role of eukaryotic-type kinases in regulation of metabolic processes such as purine biosynthesis.


Assuntos
Fosfotransferases/metabolismo , Purinas/biossíntese , Streptococcus agalactiae/genética , Streptococcus agalactiae/metabolismo , Difosfato de Adenosina/metabolismo , Monofosfato de Adenosina/metabolismo , Trifosfato de Adenosina/metabolismo , Adenilossuccinato Sintase/metabolismo , Teste de Complementação Genética , Guanosina Difosfato/metabolismo , Guanosina Monofosfato/análise , Guanosina Trifosfato/metabolismo , IMP Desidrogenase/metabolismo , Mutação , Fosforilação , Fosfotransferases/genética , Streptococcus agalactiae/crescimento & desenvolvimento
11.
Appl Environ Microbiol ; 68(11): 5464-71, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12406739

RESUMO

Alpha-galactosides are abundant sugars in legumes such as soy. Because of the lack of alpha-galactosidase (alpha-Gal) in the digestive tract, humans are unable to digest these sugars, which consequently induce flatulence. To develop the consumption of the otherwise highly nutritional soy products, the use of exogenous alpha-Gal is promising. In this framework, we characterized the melA gene for alpha-Gal in Lactobacillus plantarum. The melA gene encodes a cytoplasmic 84-kDa protein whose enzymatically active form occurs as oligomers. The melA gene was cloned and expressed in Escherichia coli, yielding an active alpha-Gal. We show that melA is transcribed from its own promoter, yielding a monocistronic mRNA, and that it is regulated at the transcriptional level, i.e., it is induced by melibiose but is not totally repressed by glucose. Posttranscriptional regulation by the carbon source could also occur. Upstream of melA, a putative galactoside transporter, designated RafP, was identified that shows high homology to LacS, the unique transporter for both alpha- and beta-galactosides in Streptococcus thermophilus. rafP is also expressed as a monocistronic mRNA. Downstream of melA, the lacL and lacM genes were identified that encode a heterodimeric beta-galactosidase. A putative galM gene identified in the same cluster suggests the presence of a galactose operon. These results indicate that the genes involved in galactoside catabolism are clustered in L. plantarum ATCC 8014. This first genetic characterization of melA and of its putative associated transporter, rafP, in a lactobacillus opens doors to various applications both in the manufacture of soy-derived products and in probiotic and nutraceutical issues.


Assuntos
Proteínas de Bactérias/genética , Lactobacillus/enzimologia , Simportadores/genética , alfa-Galactosidase/genética , Sequência de Aminoácidos , Proteínas de Bactérias/metabolismo , Sequência de Bases , DNA Bacteriano/análise , Galactosídeos/metabolismo , Lactobacillus/genética , Lactobacillus/metabolismo , Dados de Sequência Molecular , Família Multigênica , Rafinose/metabolismo , Homologia de Sequência de Aminoácidos , Simportadores/metabolismo , Transcrição Gênica , alfa-Galactosidase/metabolismo , beta-Galactosidase/genética , beta-Galactosidase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA